Standard anxiety medications — SSRIs, SNRIs, and the medications that take weeks to reach therapeutic levels in your system — have a real limitation for patients in acute distress: time. When anxiety has become severe enough to interfere with daily function, waiting four to six weeks to see if a medication works is not a neutral experience. Research on ketamine has consistently documented antidepressant and anxiolytic effects that emerge within hours rather than weeks, representing a meaningfully different treatment timeline for patients who have not responded to conventional options (National Institutes of Health, Nature). At Vitality Psychiatric Services in Midland, TX, we offer IV ketamine therapy for patients with anxiety, depression, PTSD, and chronic pain — and we think the question of how fast it works deserves a direct, evidence-grounded answer.
What Ketamine Does in the Brain
To understand the speed, you need to understand the mechanism. Most first-line anxiety and depression medications work by increasing the availability of serotonin or norepinephrine — neurotransmitters that regulate mood. They do this gradually, requiring repeated dosing over weeks before meaningful levels accumulate. Ketamine works differently. It acts on NMDA receptors in the glutamate system — the brain’s primary excitatory neurotransmitter network — producing changes in synaptic activity and neural connectivity that can occur within hours of a single dose (National Institutes of Health).
Research published in peer-reviewed journals has shown that ketamine produces rapid and significant reductions in both depressive and anxiety symptoms in clinical populations, often within the first 24 hours (National Library of Medicine). Studies have also demonstrated that ketamine rapidly restores pleasure-seeking behavior and reduces core mood symptoms ahead of other antidepressant actions — suggesting it targets the brain’s reward and distress circuitry directly and quickly (National Institute of Mental Health). For patients whose anxiety has a depressive component — which is common, given the strong bidirectional relationship between the two conditions — this dual mechanism can be particularly relevant (American Journal of Psychiatry).
The speed of effect is not a separate phenomenon from how ketamine works. It is a direct result of working on the glutamate system rather than the monoamine system. This is why the onset differs so substantially from oral antidepressants and why ketamine has become a focus of serious clinical research for patients who have not responded to conventional treatment.
What “Fast” Looks Like in Practice
Clinical research documents symptom response within hours. In practice, what patients report varies. Some notice a significant shift after a single infusion. Others experience a more gradual improvement across a series of sessions. IV ketamine is typically administered as a course of infusions rather than a single treatment, with the number and frequency of sessions determined by the patient’s clinical picture and response.
The important qualifier: results vary by individual. Ketamine is not effective for everyone, and it is not appropriate for every patient. Candidates undergo a thorough clinical evaluation before treatment is considered. Certain medical and psychiatric histories — including uncontrolled high blood pressure, a history of psychosis, or specific substance use patterns — may affect candidacy. That evaluation is not a formality; it is what allows us to give you an honest answer about whether ketamine is a realistic option for your situation.
Ketamine and Anxiety: What the Evidence Says
Research specifically on ketamine for anxiety disorders — as distinct from anxiety symptoms associated with depression — has demonstrated rapid and meaningful reductions in symptom severity for patients who have not responded to standard treatments (National Library of Medicine). The clinical evidence base for anxiety is growing, though it is less extensive than the evidence for treatment-resistant depression. This is worth naming plainly: ketamine is used off-label for anxiety disorders, meaning it is not FDA-approved for anxiety in the way it is approved as an anesthetic. What it is is supported by a meaningful and expanding clinical evidence base, and for patients who have exhausted conventional options, that distinction matters.
At Vitality, we discuss the evidence base for any treatment candidly before you make any decision. We also discuss how ketamine fits — or does not fit — alongside your existing medications and any other care you are currently receiving. For patients who may also be candidates for esketamine nasal spray, SPRAVATO® is a related FDA-approved option worth understanding as part of that conversation.
How Ketamine Therapy Works at Vitality
IV ketamine is administered in our clinic in Midland, TX under medical supervision. Tammy Vaught, APRN, CRNA, PMHNP-BC, brings 25 years of healthcare experience — including 13 years as a Certified Registered Nurse Anesthetist — to our ketamine program. That clinical background in anesthesia is directly relevant to IV infusion therapy: the safety monitoring, dosing precision, and physiological awareness involved in ketamine administration fall squarely within a CRNA’s expertise.
Your initial consultation begins with a thorough clinical evaluation that reviews your anxiety history, prior treatments, current medications, and overall health picture. If you are a candidate for ketamine, we outline what a treatment course would look like, what to expect during and after sessions, and what the realistic range of outcomes is for patients in circumstances similar to yours. Where medication management is part of your broader plan, our prescribing providers and ketamine team coordinate to ensure your care is integrated.
We accept most major insurance plans for our psychiatric services. Ketamine therapy specifically — because it is used off-label for anxiety — may have variable coverage depending on your plan, and we encourage you to verify benefits before treatment begins. Our front desk can assist with that process. Results vary by individual, and we will give you a frank picture of what the evidence supports for your specific situation. Discuss your options with your provider before committing to any treatment path.
Frequently Asked Questions
Is ketamine FDA-approved for anxiety?
Ketamine has longstanding FDA approval as an anesthetic and is used off-label to treat mood disorders including anxiety. SPRAVATO® (esketamine), a related compound, is FDA-approved specifically for treatment-resistant depression and for major depressive disorder with acute suicidal ideation or behavior — not anxiety. IV ketamine for anxiety is supported by clinical evidence but is not FDA-designated for that indication. Your provider can discuss what this means for your specific situation.
How many ketamine sessions are typically needed?
IV ketamine for mood disorders is generally administered as a series of infusions rather than a single treatment, with frequency and total sessions based on the individual patient’s response and clinical picture. Specifics are discussed during your evaluation and adjusted based on how you respond.
Will ketamine interact with my current medications?
Potentially, depending on what you are taking. This is one of the reasons a thorough clinical evaluation precedes any ketamine treatment at Vitality. Your current medication list is reviewed carefully, and any interactions or contraindications are discussed before treatment is recommended.
What does it feel like during a ketamine infusion?
Patients commonly report dissociative or perceptual effects during infusions — a sense of detachment from surroundings that resolves after the session. These effects are expected, are monitored by our clinical staff throughout the session, and do not persist after treatment ends for the vast majority of patients. Side effects from a single antidepressant dose of IV ketamine are generally mild and brief (National Institutes of Health).
Can ketamine be combined with psychotherapy?
Yes, and research suggests the combination may produce more durable outcomes than ketamine alone. At Vitality, we offer psychotherapy alongside our medical treatments, and our providers coordinate care to ensure both components are working toward the same goals.
Key Takeaways
- Ketamine works on the glutamate system — specifically NMDA receptors — rather than serotonin or norepinephrine, which accounts for its significantly faster onset compared to standard anxiety medications.
- Clinical research documents anxiolytic and antidepressant effects within hours of administration, though individual response varies.
- Ketamine is used off-label for anxiety disorders and is supported by a growing clinical evidence base; it is not FDA-approved for anxiety specifically.
- At Vitality, IV ketamine is administered under the supervision of Tammy Vaught, APRN, CRNA, PMHNP-BC, whose CRNA background is directly applicable to infusion therapy.
- A thorough clinical evaluation determines candidacy — not every patient is appropriate for ketamine, and honest assessment is part of how we work.
If standard anxiety treatments have not worked the way you hoped, ketamine may represent a different direction worth exploring. At Vitality Psychiatric Services, we evaluate candidates carefully and give you a straight answer about what the evidence supports for your situation. Call us at (432) 389-0909 or request a free consultation online to schedule your first appointment in Midland, TX. Talk with your provider about whether ketamine is an appropriate option for your care.
References
National Library of Medicine. Ketamine for anxiety. https://pubmed.ncbi.nlm.nih.gov/31339086/
Nature. Ketamine’s effectiveness for depression. https://www.nature.com/articles/s41398-021-01327-5
American Journal of Psychiatry. Link between anxiety and depression. https://psychiatryonline.org/doi/10.1176/appi.ajp.2020.20030305
National Institute of Mental Health. Rapid agent restores pleasure-seeking ahead of other antidepressant action. https://www.nimh.nih.gov/news/science-updates/2014/rapid-agent-restores-pleasure-seeking-ahead-of-other-antidepressant-action
National Institutes of Health. Side effects mild and brief: single antidepressant dose of intravenous ketamine. https://www.nih.gov/news-events/news-releases/side-effects-mild-brief-single-antidepressant-dose-intravenous-ketamine
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy for anxiety or any other condition should only be pursued under the supervision of a licensed psychiatric or medical provider familiar with your complete medical and psychiatric history. Individual results vary. Ketamine is used off-label for anxiety disorders; discuss the evidence, risks, and candidacy with a qualified provider. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.